Allogeneic hematopoietic cell transplantation (allo-HCT) for acute myeloid leukemia - prognostic factors and outcome

被引：0
|
作者：
Sakellari, I
Fassas, A
Yannaki, E
Saloum, R
Lalayanni, C
Batsis, I
Stamatopoulos, K
Eglezou, E
Kontodimou, A
Anagnostopoulos, A
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S177 / S177
页数：1
相关论文
共 50 条
  • [21] Allogeneic Hematopoietic Cell Transplantation (HCT) for Adults with Acute Myeloid Leukemia Older Than Age 60
    Vo, Phuong
    Sandmaier, Brenda M.
    Othus, Megan
    Ali, Naveed
    Rodriguez-Arboli, Eduardo
    Orvain, Corentin
    Davis, Chris
    Basom, Ryan S.
    Storb, Rainer F.
    Walter, Roland B.
    BLOOD, 2024, 144 : 7314 - 7315
  • [22] Access to Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Acute Myeloid Leukemia (AML) in the State of Virginia
    Arora, Puja
    Duarte, Luis
    Mau, Lih-Wen
    Meyer, Christa
    Senneka, Mary
    Murphy, Elizabeth A.
    Desai, Raj
    Balkrishnan, Rasjesh
    Burns, Linda J.
    Ballen, Karen K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [23] Impact of allogeneic hematopoietic cell transplantation on the outcome of older patients with acute myeloid leukemia
    Appelbaum, Frederick R.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2017, 30 (04) : 320 - 326
  • [24] The conditioning regimen intensity of allogeneic hematopoietic cell transplantation (Allo-HCT) in chronic myeloid leukemia (CML): The historical case matched comparison of ablative versus reduced intensity regimen
    Gurman, G.
    Arat, M.
    Topecuoglu, P.
    Caglayan, E. A.
    Arslan, O.
    Ozcan, M.
    Akan, H.
    Beksac, M.
    Konuk, N.
    Uysal, A.
    Koc, H.
    Ilhan, O.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 81 - 82
  • [25] Antibody response to SARS-CoV-2 vaccination in patients following allogeneic hematopoietic cell transplantation (allo-HCT)
    Huang, A.
    Cicin-Sain, C.
    Pasin, C.
    Mueller, N. J.
    Nilsson, J.
    Vilinovszki, O.
    Nair, G.
    Wolfensberger, N.
    Hockl, P.
    Schanz, U.
    Trkola, A.
    Kouyos, R.
    Hasse, B.
    Zinkernagel, A.
    Manz, M. G.
    Abela, I. A.
    Muller, A. M. S.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 64 - 65
  • [26] Minimal Residual Disease (MRD) By Either Flow Cytometry or Cytogenetics Prior to an Allogeneic Hematopoietic Cell Transplant (allo-HCT) Predicts Poor Acute Myeloid Leukemia (AML) Outcomes
    Katragadda, Lakshmikanth
    Norkin, Maxim
    Chang, Myron
    Dai, Yunfeng
    Moreb, Jan S.
    May, W. Stratford
    Coyle, Christopher R.
    Leather, Helen
    Li, Ying
    Eldjerou, Lamis K.
    Hiemenz, John W.
    Brown, Randy A.
    Wingard, John R.
    BLOOD, 2015, 126 (23)
  • [27] Risk factors for blood product usage following sibling allogeneic haemopoietic stem cell transplantation (allo-HCT)
    Hurst, Nicola
    Mullighan, Charles G.
    Heatley, Sue L.
    Robinson, Kathryn
    Danner, Silke
    Hahn, Uwe
    Szer, Jeff
    Shuttleworth, Peter
    Hoyt, Rosie
    Schwarer, Anthony P.
    Muirhead, Jenny
    Bradstock, Kenneth
    Miller, Lisa
    Bardy, Peter G.
    BLOOD, 2007, 110 (11) : 856A - 856A
  • [28] Mutational Burden before and after Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Acute Myeloid Leukemia (AML)
    Nazha, Aziz
    Hamilton, Betty K.
    Sekeres, Mikkael A.
    Mukherjee, Sudipto
    Gerds, Aaron T.
    Hanna, Rabi
    Hirsch, Cassandra M.
    Kuzmanovic, Teodora
    Al-Issa, Karam
    Przychodzen, Bartlomiej P.
    Sobecks, Ronald
    Kalaycio, Matt
    Majhail, Navneet S.
    Maciejewski, Jaroslaw P.
    BLOOD, 2017, 130
  • [29] Treatment Outcomes and Prognostic Factors of Patients with Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
    Choi, Yunsuk
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Park, Han-Seung
    Choi, Eunji
    Ko, Sun-Hye
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Lee, Je-Hwan
    BLOOD, 2016, 128 (22)
  • [30] THE OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PRIMARY REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA
    Kang, B. W.
    Sohn, S. K.
    Kang, B. W.
    Moon, J. H.
    Kim, Y. K.
    Kim, J. H.
    Song, M. K.
    Chung, J. S.
    Kim, I. H.
    Yoon, S. S.
    Park, S. Y.
    Kim, D. H.
    Jung, C. W.
    Kim, M. K.
    Hyun, M. S.
    Lee, S. M.
    Joo, Y. D.
    Park, S. K.
    Hong, D. S.
    Won, J. H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 507 - 508
12345